TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the XP Power Limited
underlying issuer of existing shares
to which voting rights are attached:
2: Reason for notification (yes/no)
An acquisition or disposal of voting rights yes
An acquisition or disposal of qualifying financial instruments which no
may result in the acquisition of shares already issued to which
voting rights are attached
An acquisition or disposal of instruments with similar economic no
effect to qualifying financial instruments
An event changing the breakdown of voting rights no
Other (please specify): no
3. Full name of person(s) subject to the Standard Life Investments Ltd
notification
obligation:
4. Full name of shareholder(s) (if Vidacos Nominees
different from 3.):
5. Date of the transaction (and date on 05 December 2011
which the threshold
is crossed or reached):
6. Date on which issuer notified: 06 December 2011
7. Threshold(s) that is/are crossed or 10%
reached:
8: Notified Details
A. Voting rights attached to shares
* Class/type of share If possible SG9999003735
use ISIN code
Situation previous to the triggering transaction
* Number of shares * Number of voting rights
1,993,200 1,993,200
Resulting situation after the triggering transaction
* Number of Number of voting rights Percentage of
shares voting rights
Direct Indirect Direct Indirect
1,917,282 366,220 1,551,062 1.903% 8.061%
B. Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ No. of voting Percentage of
financial date conversion rights that may voting rights
instrument period/date be acquired
(if the
instrument
exercised/
converted)
Delta
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
Resulting situation after the triggering transaction
Type of financial Exercise Expiration Exercise/ Number of % of voting
instrument price date Conversion voting rights
period rights
instrument
refers to
Nominal
Total (A+B+C)
Number of voting rights Percentage of voting rights
1,917,282 9.964%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will
cease to hold:
12. Date on which proxy holder will cease to
hold voting rights:
13. Additional information:
14. Contact name: Duncan Penny
15. Contact telephone number: +65 8322 9520
Facsimile
Citibank, N.A., London Branch
Registered as a branch in the UK at Citigroup Centre, 33 Canada Square, London
E14 5LB. Registered number BR001018.
Authorised and regulated by the Financial Services Authority.
Citibank, N.A. is incorporated with limited liability in the USA. Head office:
399 Park Ave, New York, NY 10022-4699.
This message is intended only for the use of the individual(s) named above and
may contain confidential information.
If you are not the named addressee or an employee or agent responsible for
delivering this message to the named addressee, you are not authorised to
retain, read, copy or disseminate this message or any part of it. If you have
received this message in error, please notify us immediately by telephone and
return the original facsimile to us at the above address.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.